Desq Long
Sign in

Company

Zentalis Pharmaceuticals, Inc.

ZNTL · CIK 0001725160

SEC FORM 4
$15,172,500.00

Zentalis Pharmaceuticals, Inc. (ZNTL)

Purchase of 4,335,000 shares at $3.5 per share.

Reporting Persons WALTERS GROUP · WALTERS WILLIAM THURMAN · WALTERS SUSAN BERKLEY · Transaction Code P

Traded Aug 14, 2026 · Disclosed Aug 19, 2026FILED +5 DAYS

Source: SEC Form 4 · 0001213900-26-091823 · filed 2026-08-19 · View filing →